Physician profile
Windy A Bowman
NPI 1548591498
$1,371.42
in general payments reported to CMS, 2019-2025
15 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.77 · 2022: $293 · 2023: $468 · 2024: $155 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $246.12 | 2023-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $206.96 | 2023-2025 | Belbuca |
| Grt US Holding, INC. | $176.18 | 2022 | |
| Nevro Corp. | $138.44 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $113.27 | 2023-2024 | Evoke Scs, Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $106.21 | 2022-2025 | Relistor |
| Spr Therapeutics, INC | $93.74 | 2022-2025 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $76.36 | 2023-2025 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $57.13 | 2025 | |
| Medtronic, INC. | $36.64 | 2022-2023 | Intellis Adaptivestim |
| Valinor Pharma, LLC | $34.22 | 2025 | Movantik |
| Allergan, INC. | $24.77 | 2021 | |
| Baxter Healthcare | $23.16 | 2025 | Floseal |
| Globus Medical, INC. | $20.20 | 2024 | Quartex, Sable |
| Kls-Martin L.P. | $18.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Windy Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.